SKU: MF1011

MaxFrari 5 Agonist MAX CODED Weight Loss Compound x 1 dose @ 21.5mg – Cartridge Only

21.5mg per dose, 1 dose cartridge

Please recognize the extreme use of this product and that there can be extreme side effects if you do not tolerate the individual research elements of Tirzpepatide and Retatrutide well. Use this drug and dosage only if you have problems losing appetite with individual elements only.

Top of the line research maximum appetite and urge suppressant drug is the combination of Tirzepatide and Retatrutide to offer the following benefits:

Combined Effect

  • Synergistic Action: When used together, tirzepatide and retatrutide may have a synergistic effect. The dual action of tirzepatide on GLP-1 and GIP receptors, combined with the triple action of retatrutide on GLP-1, GIP, and glucagon receptors, could enhance weight loss through multiple pathways.
  • Comprehensive Metabolic Regulation: This combination can provide comprehensive regulation of glucose metabolism, appetite, and energy expenditure, making it potentially more effective for weight loss than either agent alone.
  • Improved Satiety and Reduced Caloric Intake: The enhanced appetite suppression and prolonged satiety from both medications can lead to significant reductions in caloric intake.
  • Increased Fat Burning: The glucagon receptor activation by retatrutide can boost fat metabolism, contributing to greater fat loss.

$85.00